Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
3.200
+0.130 (4.23%)
Oct 20, 2026, 4:00 PM EDT - Market closed
Armata Pharmaceuticals Employees
Armata Pharmaceuticals had 61 employees as of December 31, 2025. The number of employees increased by 1 or 1.67% compared to the previous year. That makes Armata Pharmaceuticals the 34,022nd largest employer in the world and 4,504th in the United States.
Employees
61
Change (1Y)
1
Growth (1Y)
1.67%
Revenue / Employee
$90,869
Profits / Employee
-$3,150,459
Market Cap
118.98M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 61 | 1 | 1.67% | 61 | 0 |
| Dec 31, 2024 | 60 | -6 | -9.09% | 60 | 0 |
| Dec 31, 2023 | 66 | -9 | -12.00% | 66 | 0 |
| Dec 31, 2022 | 75 | 4 | 5.63% | 72 | 3 |
| Dec 31, 2021 | 71 | 9 | 14.52% | 69 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Humacyte | 184 |
| Nkarta | 106 |
| Korro Bio | 57 |
| Anavex Life Sciences | 34 |
| Cue Biopharma | 29 |
| Spruce Biosciences | 22 |
| TuHURA Biosciences | 22 |
| AN2 Therapeutics | 21 |
ARMP News
- 13 days ago - Armata announces two new patents covering bacteriophage programs - TheFly
- 13 days ago - Armata Pharmaceuticals Strengthens Intellectual Property Portfolio with Two Recent Patent Issuances in the United States - PRNewsWire
- 27 days ago - Armata Pharmaceuticals receives $3.7M in additional funding from DoW - TheFly
- 27 days ago - Armata Pharmaceuticals Receives $3.7 Million in Additional Non-Dilutive Funding from U.S. Department of War to Support Advancement of AP-SA02 Phase 3 Development - PRNewsWire
- 4 weeks ago - Armata Pharmaceuticals to Present Data at ISSSI 2026 Showing Defined Genetic Diversity in AP-SA02 May Enhance Killing of Certain Staphylococcus aureus Clinical Isolates - PRNewsWire
- 5 weeks ago - Armata Pharmaceuticals receives FDA Breakthrough Therapy Designation for AP-SA02 - TheFly
- 5 weeks ago - Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02 - PRNewsWire
- 5 weeks ago - Armata Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - PRNewsWire